In the high-UTI-risk group, the curve of cumulative incidence
of clinically defined UTI showed a positive treatment
effect from 2 months of follow-up onward (P = .03). No
such effect was found for strictly defined UTI (P = .91).
There was no difference between cranberry and placebo in
the low-UTI-risk group (Figure 2).